Curcumin Inhibits Rift Valley Fever Virus Replication in Human Cells

Aarthi Narayanan, Kylene Kehn‐Hall, Svetlana Senina, +11

Journal of Biological Chemistry

Modulation of GSK-3β Activity in Venezuelan Equine Encephalitis Virus Infection

Kylene Kehn‐Hall, Aarthi Narayanan, Lindsay Lundberg, +10

PLoS ONE

Protective Immunity against Respiratory Tract Challenge with<i>Yersinia pestis</i>in Mice Immunized with an Adenovirus‐Based Vaccine Vector Expressing V Antigen

Marı́a J. Chiuchiolo, Julie L. Boyer, Anja Krause, +3

The Journal of Infectious Diseases

Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection

Ashwini Benedict, Neha Bansal, Svetlana Senina, +6

Frontiers in Microbiology

VaccinationMolecular VirologyViral DiagnosticsVirus Infectious CycleSynthetic Virology +12

The Role of IKKβ in Venezuelan Equine Encephalitis Virus Infection

Moushimi Amaya, Kelsey Voss, Gavin C. Sampey, +11

PLoS ONE

An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge

Amy Palin, Anasuya Chattopadhyay, Steven Park, +4

Vaccine

VaccinationVaccine DevelopmentVaccine TargetOptimized Vaccine VectorPathogenesis +9

Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection

Anasuya Chattopadhyay, Steven Park, Rema Suresh, +3

Vaccine

VaccinationVaccine DevelopmentCd4+ CellsImmunologyVirus-vectored Vaccine Protection +6

Novel Neuroprotective GSK-3β Inhibitor Restricts Tat-Mediated HIV-1 Replication

Irene Guendel, Sergey Iordanskiy, Rachel Van Duyne, +12

Journal of Virology

Hiv-1 TranscriptionImmunologyUnique CompoundsAntiviral DrugImmune System +15

Adenovirus-Mediated Delivery of an Anti-V Antigen Monoclonal Antibody Protects Mice against a Lethal <i>Yersinia pestis</i> Challenge

Carolina Sofer-Podesta, John Ang, Neil R. Hackett, +4

Infection and Immunity

ImmunologyImmunotherapyVaccine TargetPneumonic PlagueVaccine Development +14

Protective Immunity Against a Lethal Respiratory <i>Yersinia pestis</i> Challenge Induced by V Antigen or the F1 Capsular Antigen Incorporated into Adenovirus Capsid

Julie L. Boyer, Carolina Sofer-Podesta, John Ang, +5

Human Gene Therapy